A systematic review on the quality, validity and usefulness of current cost‐effectiveness studies for treatments of neovascular age‐related macular degeneration
Sign Up to like & getrecommendations! Published in 2018 at "Acta Ophthalmologica"
DOI: 10.1111/aos.13824
Abstract: Ophthalmologists increasingly depend on new drugs to advance their treatment options. These options are limited by restraints on reimbursements for new and expensive drugs. These restraints are put in place through health policy decisions based… read more here.
Keywords: quality validity; validity usefulness; cost effectiveness; cost ... See more keywords